Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pmd-026 (1 trial)
Breast Neoplasms (Phase 1)
Triple Negative Breast Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (1 total)